Trevor Robbins

The CANTAB PAL touchscreen test, which assesses visual memory and new learning, received the highest rating of world-leading 4* grade from the Research Excellence Framework (REF) 2014. Following this award, CANTAB and CANTAB PAL were highlighted in the Medical Schools Council 'Health of the Nation' 2015 publication, which described CANTAB as a boost to the UK economy. Robbins is also a co-author of the neurochemical Functional Ensemble of Temperament model that mapped the functional roles of brain neurotransmitters to main aspects of behavioural regulation.

The work of Robbins and his collaborators led to the formation of the BCNI in 2005, which is jointly funded by the Medical Research Council (MRC) and the Wellcome Trust. Robbins is director of the institute, which focuses on translational work leading to the treatment of neuropsychiatric disorders.

Robbins Chaired the MRC Neuroscience and Mental Health Research Board between 1995 and 1999, and was co-leader of the UK Government 2005 Foresight Project entitled 'Drug Futures 2025?'. He has also consulted for the Prime Minister of the United Kingdom on the state of UK research. Since 2005, Robbins has been a Fellow of the Royal Society. In addition, he is a Fellow of the British Psychological Society (since 1990) and a Fellow of the Academy of Medical Sciences (since 2000).

Robbins has published over 850 full papers in scientific journals, including Nature, Brain, Science and Nature Neuroscience. The ISI Web of Science credits Robbins with a Hirsch (h) index of 199 and is credited as one of the top cited authors in Neuroscience. He has been an editor of the journal Psychopharmacology since 1980, is a Member of the Editorial Board of the journal Science, and is Co-Editor-in-Chief of the journal Current Opinion in Behavioral Sciences. In 2017–2018 he was a guest co-editor of a theme issue of the Philosophical Transactions of the Royal Society. Robbins has co-edited 7 books, including Psychology for Medicine, The Neurobiology of Addiction and Decision Making, Effect and Learning.

Robbins' research uses neuropsychological tests, such as the Cambridge Neuropsychological Test Automated Battery (CANTAB), which he co-invented with Professor Barbara Sahakian in the 1980s. CANTAB is now used at over 700 research institutes worldwide and is backed by over 1,200 peer-review articles. Robbins serves as a Senior Consultant to Cambridge Cognition, a spin-out of the University of Cambridge. Cambridge Cognition now provides CANTAB.

Robbins was appointed as a Demonstrator in the Department of Experimental Psychology at the University of Cambridge in 1973. He was subsequently promoted to Lecturer and Reader, before becoming Professor of Cognitive Neuroscience in 1997. Robbins was elected to the Chair, and therefore Head of Department, of Psychology in October 2002, stepping down from the latter role in 2017.

Following admittance in Jesus College at the University of Cambridge, Robbins obtained his Bachelor of Arts (First Class Honours) in psychology in 1971. Following this, he received his PhD degree from the University of Cambridge in 1975 for an analysis of the behavioural effects of Dextroamphetamine.

Robbins is a keen chess player and represented both England Juniors in 1967 and the University of Cambridge as an undergraduate. He was once ranked in the top twenty players in England and had one of his wins from a Varsity match in 1970 featured as a classic game in The Sunday Times.